Effects of long-acting calcium channel antagonists on neurohumoral factors: Comparison of nifedipine coat-core with amlodipine

Journal of Cardiovascular Pharmacology

Volumn 41, Issue SUPPL. 1, 2003, Pages

  Tsutamoto, Takayoshi ^a   Tsutsui, Takashi ^a   Maeda, Keiko ^a   Hayashi, Masaru ^a   Wada, Atsuyuki ^a   Ohnishi, Masato ^a   Fujii, Masanori ^a   Ishii, Chitose ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Aldosterone; Amlodipine; Hypertension; Nifedipine coat core; Norepinephrine; Renin

Indexed keywords

ALDOSTERONE; AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; NIFEDIPINE COAT CORE; NORADRENALIN; RENIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG FORMULATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPERTENSION; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUSTAINED RELEASE PREPARATION; SYMPATHETIC NERVE;

AGED; AGED, 80 AND OVER; ALDOSTERONE; AMLODIPINE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; CHI-SQUARE DISTRIBUTION; DELAYED-ACTION PREPARATIONS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; NIFEDIPINE; NOREPINEPHRINE; RENIN;

EID: 0037214325     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Psaty BM, Smith NL, Siscovick DS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-5.
2. Pahor M, Guralnik JM, Corti MC, et al. Long-term survival and use of antihypertensive medications in older patients. J Am Geriatr Soc 1995;43:1191-7.
3. Furberg CD, Psaty BM, Meyer JV. Nifedipine; dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31.
4. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.
5. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996;14:1237-45.
6. Hansson L, Zanchetti A, Carruthers SC, et al. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998;351:703-12.
7. Pahor M, Psaty BM, Alderman MH, et al. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta analysis of randomized controlled trials. Lancet 2000;356:1949-54.
8. Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialist's Collaboration: Effects of ACE inhibitors, calcium antagonists and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomized trials. Lancet 2000;356:1955-64.
9. Tsutamoto T, Wada A, Maeda K, et al. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 2001;37:1228-33.
10. Baba S. Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics. Diabetes Res Clin Prac 2001;54:191-201.
11. Brown MJ Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet 2000;356:366-72.
12. Kleinbloesem CH, van Brummelen P, van de Linde JA, et al. Nifedipine: Kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 1984;35:742-9.
13. Kleinbloesem CH, van Brummelen P, Danhof M, et al. Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther 1987;41:26-30.
14. Hamada T, Watanabe M, Kaneda T, et al. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998; 16:111-8.
15. de Champlain J, Karas M, Nguyen P, et al. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998;16:1357-69.
16. Packer M, O'Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996;335:1107-14.
17. O'Connor CM, Carson PE, Miller AB, et al. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial: Prospective Randomized Amlodipine Survival Evaluation. Am J Cardiol 1998;82:881-7.